It was noted that PO successfully play a role as a competitive uricase inhibitor since the XO activity in the hyperuricemic gout control group (GC) was significantly increased (p < 0.05) at a level of 12.77 ± 0.33 mU/mL. The gene discussed is XDH; the disease is gout.